Connect Biopharma : INFORMATION CONTAINED IN THIS REPORT ON FORM 6 K Form 6 K

Document



















UNITED STATES


SECURITIES...

Related Keywords

California ,United States ,San Diego ,San Francisco ,Irvine ,Washington ,Kleanthisg Xanthopoulos ,Zheng Wei ,David Szekeres ,Patara Pharma ,Steven Chan ,Sanford Burnham Preby ,Wubin Pan ,University Of California ,Counsel At Regulus Therapeutics Inc ,Warner Lambert Company ,Exchange Commission ,Roivant Sciences ,Heron Therapeutics Inc ,Agouron Pharmaceuticals Inc ,Company Registration Statement On Form ,Exchange Commission On ,Edico Genome Inc ,Pfizer Inc ,Head Of Finance Heron Therapeutics Inc ,Nasdaq ,Duke University School Of Law ,Commission File Number ,Securities Exchange ,Ardea Biosciences Inc ,Nasdaq Stock Market ,Life Technologies Corporation ,Biopharma Holdings Limited The Company ,Pfizer Global Research ,Kiniksa Pharmaceuticals Ltd ,Biopharma Holdings ,File Number ,Camino Real ,Regulationst Rule ,Certain Officers ,Connect Biopharma Holdings Limited ,Chief Executive Officer ,Barry Quart ,Heron Therapeutics ,Ardea Biosciences ,Senior Vice President ,Agouron Pharmaceuticals ,Kiniksa Pharmaceuticals ,Indemnification Agreement ,Registration Statement ,Regulations K ,Securities Act ,Chief Operating Officer ,Chief Business Officer ,Principal Financial Officer ,General Counsel ,Regulus Therapeutics ,Thermo Fisher Scientific ,Edico Genome ,Duke University School ,Inducement Incentive Award Plan ,Incentive Plan ,Inducement Plan ,Nasdaq Listing ,Nasdaq Listing Rules ,Connect Biopharm ,Securities Exchange Act ,